A comprehensive view of vaccination/immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Novavax expects to start Phase 2 COVID-19, flu combined vaccine trial by end of 2022; initial Phase 1/2 trial data show various formulations of the combination vaccine induced immune responses in participants comparable to stand-alone shots
Published: May 19, 2022 by SeeNews Pharmaceuticals
Bavarian Nordic to make freeze-dried version of its Jynneos smallpox vaccine for US government in US$119M deal, with vaccine production in 2023, 2024; up to 13 million doses could be made if US exercises additional US$180M option
Published: May 19, 2022 by SeeNews Pharmaceuticals
CDC considers expanding COVID-19 booster eligibility to people under 50 as cases rise to 94,000 per day, with seven-day case average rising 26% from the previous week and hospitalizations up 19% to 3,000 per day; additional dose requires FDA approval
Published: May 19, 2022 by Reuters
FDA approves Pfizer COVID-19 booster shots for healthy 5-to-11 year-old children, as CDC decides whether to approved booster; about 30% of eligible kids in 5-to-11 age group have received two doses of Pfizer vaccination
Published: May 18, 2022 by Associated Press
Atrium Health Levine Children’s Hospital in Charlotte, North Carolina, starts Pfizer-BioNTech COVID-19 vaccine study in healthy children ages six months old to under five years of age; over 350 million doses of the vaccine have been administered in US
Published: May 17, 2022 by Contify Life Science News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count